The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-oncology Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 NGS
1.2.4 Immunoassay
1.3 Market by Application
1.3.1 Global Immuno-oncology Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research
1.3.3 Diagnostics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-oncology Diagnosis Market Perspective (2019-2030)
2.2 Immuno-oncology Diagnosis Growth Trends by Region
2.2.1 Global Immuno-oncology Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immuno-oncology Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Immuno-oncology Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Immuno-oncology Diagnosis Market Dynamics
2.3.1 Immuno-oncology Diagnosis Industry Trends
2.3.2 Immuno-oncology Diagnosis Market Drivers
2.3.3 Immuno-oncology Diagnosis Market Challenges
2.3.4 Immuno-oncology Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-oncology Diagnosis Players by Revenue
3.1.1 Global Top Immuno-oncology Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Immuno-oncology Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Immuno-oncology Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-oncology Diagnosis Revenue
3.4 Global Immuno-oncology Diagnosis Market Concentration Ratio
3.4.1 Global Immuno-oncology Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-oncology Diagnosis Revenue in 2023
3.5 Immuno-oncology Diagnosis Key Players Head office and Area Served
3.6 Key Players Immuno-oncology Diagnosis Product Solution and Service
3.7 Date of Enter into Immuno-oncology Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-oncology Diagnosis Breakdown Data by Type
4.1 Global Immuno-oncology Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Immuno-oncology Diagnosis Forecasted Market Size by Type (2025-2030)
5 Immuno-oncology Diagnosis Breakdown Data by Application
5.1 Global Immuno-oncology Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Immuno-oncology Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immuno-oncology Diagnosis Market Size (2019-2030)
6.2 North America Immuno-oncology Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immuno-oncology Diagnosis Market Size by Country (2019-2024)
6.4 North America Immuno-oncology Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-oncology Diagnosis Market Size (2019-2030)
7.2 Europe Immuno-oncology Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immuno-oncology Diagnosis Market Size by Country (2019-2024)
7.4 Europe Immuno-oncology Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-oncology Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Immuno-oncology Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immuno-oncology Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Immuno-oncology Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno-oncology Diagnosis Market Size (2019-2030)
9.2 Latin America Immuno-oncology Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immuno-oncology Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Immuno-oncology Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-oncology Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Immuno-oncology Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immuno-oncology Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Immuno-oncology Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Immuno-oncology Diagnosis Introduction
11.1.4 10x Genomics Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.1.5 10x Genomics Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Immuno-oncology Diagnosis Introduction
11.2.4 Abbott Laboratories Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam Immuno-oncology Diagnosis Introduction
11.3.4 Abcam Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Adaptive Biotechnologies
11.4.1 Adaptive Biotechnologies Company Detail
11.4.2 Adaptive Biotechnologies Business Overview
11.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Introduction
11.4.4 Adaptive Biotechnologies Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.4.5 Adaptive Biotechnologies Recent Development
11.5 Aethlon Medical
11.5.1 Aethlon Medical Company Detail
11.5.2 Aethlon Medical Business Overview
11.5.3 Aethlon Medical Immuno-oncology Diagnosis Introduction
11.5.4 Aethlon Medical Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.5.5 Aethlon Medical Recent Development
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Detail
11.6.2 Agena Bioscience Business Overview
11.6.3 Agena Bioscience Immuno-oncology Diagnosis Introduction
11.6.4 Agena Bioscience Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.6.5 Agena Bioscience Recent Development
11.7 Angle plc
11.7.1 Angle plc Company Detail
11.7.2 Angle plc Business Overview
11.7.3 Angle plc Immuno-oncology Diagnosis Introduction
11.7.4 Angle plc Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.7.5 Angle plc Recent Development
11.8 Apocell
11.8.1 Apocell Company Detail
11.8.2 Apocell Business Overview
11.8.3 Apocell Immuno-oncology Diagnosis Introduction
11.8.4 Apocell Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.8.5 Apocell Recent Development
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Detail
11.9.2 ARUP Laboratories Business Overview
11.9.3 ARUP Laboratories Immuno-oncology Diagnosis Introduction
11.9.4 ARUP Laboratories Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.9.5 ARUP Laboratories Recent Development
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Detail
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter Immuno-oncology Diagnosis Introduction
11.10.4 Beckman Coulter Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.10.5 Beckman Coulter Recent Development
11.11 Becton Dickinson
11.11.1 Becton Dickinson Company Detail
11.11.2 Becton Dickinson Business Overview
11.11.3 Becton Dickinson Immuno-oncology Diagnosis Introduction
11.11.4 Becton Dickinson Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.11.5 Becton Dickinson Recent Development
11.12 Bioarray Genetics
11.12.1 Bioarray Genetics Company Detail
11.12.2 Bioarray Genetics Business Overview
11.12.3 Bioarray Genetics Immuno-oncology Diagnosis Introduction
11.12.4 Bioarray Genetics Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.12.5 Bioarray Genetics Recent Development
11.13 BioCartis
11.13.1 BioCartis Company Detail
11.13.2 BioCartis Business Overview
11.13.3 BioCartis Immuno-oncology Diagnosis Introduction
11.13.4 BioCartis Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.13.5 BioCartis Recent Development
11.14 Biocept
11.14.1 Biocept Company Detail
11.14.2 Biocept Business Overview
11.14.3 Biocept Immuno-oncology Diagnosis Introduction
11.14.4 Biocept Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.14.5 Biocept Recent Development
11.15 Biodesix Inc
11.15.1 Biodesix Inc Company Detail
11.15.2 Biodesix Inc Business Overview
11.15.3 Biodesix Inc Immuno-oncology Diagnosis Introduction
11.15.4 Biodesix Inc Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.15.5 Biodesix Inc Recent Development
11.16 BioFluidica
11.16.1 BioFluidica Company Detail
11.16.2 BioFluidica Business Overview
11.16.3 BioFluidica Immuno-oncology Diagnosis Introduction
11.16.4 BioFluidica Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.16.5 BioFluidica Recent Development
11.17 BioGenex 40 bioMérieux
11.17.1 BioGenex 40 bioMérieux Company Detail
11.17.2 BioGenex 40 bioMérieux Business Overview
11.17.3 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Introduction
11.17.4 BioGenex 40 bioMérieux Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.17.5 BioGenex 40 bioMérieux Recent Development
11.18 Bio-Rad
11.18.1 Bio-Rad Company Detail
11.18.2 Bio-Rad Business Overview
11.18.3 Bio-Rad Immuno-oncology Diagnosis Introduction
11.18.4 Bio-Rad Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.18.5 Bio-Rad Recent Development
11.19 Bio-Techne
11.19.1 Bio-Techne Company Detail
11.19.2 Bio-Techne Business Overview
11.19.3 Bio-Techne Immuno-oncology Diagnosis Introduction
11.19.4 Bio-Techne Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.19.5 Bio-Techne Recent Development
11.20 Bristol-Myers Squibb
11.20.1 Bristol-Myers Squibb Company Detail
11.20.2 Bristol-Myers Squibb Business Overview
11.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Introduction
11.20.4 Bristol-Myers Squibb Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.20.5 Bristol-Myers Squibb Recent Development
11.21 Cancer Genetics
11.21.1 Cancer Genetics Company Detail
11.21.2 Cancer Genetics Business Overview
11.21.3 Cancer Genetics Immuno-oncology Diagnosis Introduction
11.21.4 Cancer Genetics Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.21.5 Cancer Genetics Recent Development
11.22 Caris Molecular Diagnostics
11.22.1 Caris Molecular Diagnostics Company Detail
11.22.2 Caris Molecular Diagnostics Business Overview
11.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Introduction
11.22.4 Caris Molecular Diagnostics Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.22.5 Caris Molecular Diagnostics Recent Development
11.23 CellMax Life
11.23.1 CellMax Life Company Detail
11.23.2 CellMax Life Business Overview
11.23.3 CellMax Life Immuno-oncology Diagnosis Introduction
11.23.4 CellMax Life Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.23.5 CellMax Life Recent Development
11.24 Charles River Laboratories
11.24.1 Charles River Laboratories Company Detail
11.24.2 Charles River Laboratories Business Overview
11.24.3 Charles River Laboratories Immuno-oncology Diagnosis Introduction
11.24.4 Charles River Laboratories Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.24.5 Charles River Laboratories Recent Development
11.25 Chronix Biomedical
11.25.1 Chronix Biomedical Company Detail
11.25.2 Chronix Biomedical Business Overview
11.25.3 Chronix Biomedical Immuno-oncology Diagnosis Introduction
11.25.4 Chronix Biomedical Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.25.5 Chronix Biomedical Recent Development
11.26 Circulogene
11.26.1 Circulogene Company Detail
11.26.2 Circulogene Business Overview
11.26.3 Circulogene Immuno-oncology Diagnosis Introduction
11.26.4 Circulogene Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.26.5 Circulogene Recent Development
11.27 Clearbridge BioMedics
11.27.1 Clearbridge BioMedics Company Detail
11.27.2 Clearbridge BioMedics Business Overview
11.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Introduction
11.27.4 Clearbridge BioMedics Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.27.5 Clearbridge BioMedics Recent Development
11.28 Clinical Genomics
11.28.1 Clinical Genomics Company Detail
11.28.2 Clinical Genomics Business Overview
11.28.3 Clinical Genomics Immuno-oncology Diagnosis Introduction
11.28.4 Clinical Genomics Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.28.5 Clinical Genomics Recent Development
11.29 Pfizer
11.29.1 Pfizer Company Detail
11.29.2 Pfizer Business Overview
11.29.3 Pfizer Immuno-oncology Diagnosis Introduction
11.29.4 Pfizer Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.29.5 Pfizer Recent Development
11.30 Promega
11.30.1 Promega Company Detail
11.30.2 Promega Business Overview
11.30.3 Promega Immuno-oncology Diagnosis Introduction
11.30.4 Promega Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.30.5 Promega Recent Development
11.31 Protagen Diagnostics
11.31.1 Protagen Diagnostics Company Detail
11.31.2 Protagen Diagnostics Business Overview
11.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Introduction
11.31.4 Protagen Diagnostics Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.31.5 Protagen Diagnostics Recent Development
11.32 Qiagen
11.32.1 Qiagen Company Detail
11.32.2 Qiagen Business Overview
11.32.3 Qiagen Immuno-oncology Diagnosis Introduction
11.32.4 Qiagen Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.32.5 Qiagen Recent Development
11.33 Quanterix
11.33.1 Quanterix Company Detail
11.33.2 Quanterix Business Overview
11.33.3 Quanterix Immuno-oncology Diagnosis Introduction
11.33.4 Quanterix Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.33.5 Quanterix Recent Development
11.34 Rarecells SAS
11.34.1 Rarecells SAS Company Detail
11.34.2 Rarecells SAS Business Overview
11.34.3 Rarecells SAS Immuno-oncology Diagnosis Introduction
11.34.4 Rarecells SAS Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.34.5 Rarecells SAS Recent Development
11.35 Roche Diagnostics
11.35.1 Roche Diagnostics Company Detail
11.35.2 Roche Diagnostics Business Overview
11.35.3 Roche Diagnostics Immuno-oncology Diagnosis Introduction
11.35.4 Roche Diagnostics Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.35.5 Roche Diagnostics Recent Development
11.36 Siemens
11.36.1 Siemens Company Detail
11.36.2 Siemens Business Overview
11.36.3 Siemens Immuno-oncology Diagnosis Introduction
11.36.4 Siemens Revenue in Immuno-oncology Diagnosis Business (2019-2024)
11.36.5 Siemens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Immuno-oncology Diagnosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of PCR
Table 3. Key Players of NGS
Table 4. Key Players of Immunoassay
Table 5. Global Immuno-oncology Diagnosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Immuno-oncology Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Immuno-oncology Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Immuno-oncology Diagnosis Market Share by Region (2019-2024)
Table 9. Global Immuno-oncology Diagnosis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Immuno-oncology Diagnosis Market Share by Region (2025-2030)
Table 11. Immuno-oncology Diagnosis Market Trends
Table 12. Immuno-oncology Diagnosis Market Drivers
Table 13. Immuno-oncology Diagnosis Market Challenges
Table 14. Immuno-oncology Diagnosis Market Restraints
Table 15. Global Immuno-oncology Diagnosis Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Immuno-oncology Diagnosis Market Share by Players (2019-2024)
Table 17. Global Top Immuno-oncology Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Diagnosis as of 2023)
Table 18. Ranking of Global Top Immuno-oncology Diagnosis Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Immuno-oncology Diagnosis Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immuno-oncology Diagnosis Product Solution and Service
Table 22. Date of Enter into Immuno-oncology Diagnosis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immuno-oncology Diagnosis Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Immuno-oncology Diagnosis Revenue Market Share by Type (2019-2024)
Table 26. Global Immuno-oncology Diagnosis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Immuno-oncology Diagnosis Revenue Market Share by Type (2025-2030)
Table 28. Global Immuno-oncology Diagnosis Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Immuno-oncology Diagnosis Revenue Market Share by Application (2019-2024)
Table 30. Global Immuno-oncology Diagnosis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Immuno-oncology Diagnosis Revenue Market Share by Application (2025-2030)
Table 32. North America Immuno-oncology Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Immuno-oncology Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Immuno-oncology Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Immuno-oncology Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Immuno-oncology Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Immuno-oncology Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Immuno-oncology Diagnosis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Immuno-oncology Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Immuno-oncology Diagnosis Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Immuno-oncology Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Immuno-oncology Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Immuno-oncology Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Immuno-oncology Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Immuno-oncology Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Immuno-oncology Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 47. 10x Genomics Company Detail
Table 48. 10x Genomics Business Overview
Table 49. 10x Genomics Immuno-oncology Diagnosis Product
Table 50. 10x Genomics Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 51. 10x Genomics Recent Development
Table 52. Abbott Laboratories Company Detail
Table 53. Abbott Laboratories Business Overview
Table 54. Abbott Laboratories Immuno-oncology Diagnosis Product
Table 55. Abbott Laboratories Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 56. Abbott Laboratories Recent Development
Table 57. Abcam Company Detail
Table 58. Abcam Business Overview
Table 59. Abcam Immuno-oncology Diagnosis Product
Table 60. Abcam Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 61. Abcam Recent Development
Table 62. Adaptive Biotechnologies Company Detail
Table 63. Adaptive Biotechnologies Business Overview
Table 64. Adaptive Biotechnologies Immuno-oncology Diagnosis Product
Table 65. Adaptive Biotechnologies Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 66. Adaptive Biotechnologies Recent Development
Table 67. Aethlon Medical Company Detail
Table 68. Aethlon Medical Business Overview
Table 69. Aethlon Medical Immuno-oncology Diagnosis Product
Table 70. Aethlon Medical Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 71. Aethlon Medical Recent Development
Table 72. Agena Bioscience Company Detail
Table 73. Agena Bioscience Business Overview
Table 74. Agena Bioscience Immuno-oncology Diagnosis Product
Table 75. Agena Bioscience Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 76. Agena Bioscience Recent Development
Table 77. Angle plc Company Detail
Table 78. Angle plc Business Overview
Table 79. Angle plc Immuno-oncology Diagnosis Product
Table 80. Angle plc Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 81. Angle plc Recent Development
Table 82. Apocell Company Detail
Table 83. Apocell Business Overview
Table 84. Apocell Immuno-oncology Diagnosis Product
Table 85. Apocell Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 86. Apocell Recent Development
Table 87. ARUP Laboratories Company Detail
Table 88. ARUP Laboratories Business Overview
Table 89. ARUP Laboratories Immuno-oncology Diagnosis Product
Table 90. ARUP Laboratories Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 91. ARUP Laboratories Recent Development
Table 92. Beckman Coulter Company Detail
Table 93. Beckman Coulter Business Overview
Table 94. Beckman Coulter Immuno-oncology Diagnosis Product
Table 95. Beckman Coulter Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 96. Beckman Coulter Recent Development
Table 97. Becton Dickinson Company Detail
Table 98. Becton Dickinson Business Overview
Table 99. Becton Dickinson Immuno-oncology Diagnosis Product
Table 100. Becton Dickinson Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 101. Becton Dickinson Recent Development
Table 102. Bioarray Genetics Company Detail
Table 103. Bioarray Genetics Business Overview
Table 104. Bioarray Genetics Immuno-oncology Diagnosis Product
Table 105. Bioarray Genetics Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 106. Bioarray Genetics Recent Development
Table 107. BioCartis Company Detail
Table 108. BioCartis Business Overview
Table 109. BioCartis Immuno-oncology Diagnosis Product
Table 110. BioCartis Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 111. BioCartis Recent Development
Table 112. Biocept Company Detail
Table 113. Biocept Business Overview
Table 114. Biocept Immuno-oncology Diagnosis Product
Table 115. Biocept Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 116. Biocept Recent Development
Table 117. Biodesix Inc Company Detail
Table 118. Biodesix Inc Business Overview
Table 119. Biodesix Inc Immuno-oncology Diagnosis Product
Table 120. Biodesix Inc Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 121. Biodesix Inc Recent Development
Table 122. BioFluidica Company Detail
Table 123. BioFluidica Business Overview
Table 124. BioFluidica Immuno-oncology Diagnosis Product
Table 125. BioFluidica Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 126. BioFluidica Recent Development
Table 127. BioGenex 40 bioMérieux Company Detail
Table 128. BioGenex 40 bioMérieux Business Overview
Table 129. BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product
Table 130. BioGenex 40 bioMérieux Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 131. BioGenex 40 bioMérieux Recent Development
Table 132. Bio-Rad Company Detail
Table 133. Bio-Rad Business Overview
Table 134. Bio-Rad Immuno-oncology Diagnosis Product
Table 135. Bio-Rad Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 136. Bio-Rad Recent Development
Table 137. Bio-Techne Company Detail
Table 138. Bio-Techne Business Overview
Table 139. Bio-Techne Immuno-oncology Diagnosis Product
Table 140. Bio-Techne Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 141. Bio-Techne Recent Development
Table 142. Bristol-Myers Squibb Company Detail
Table 143. Bristol-Myers Squibb Business Overview
Table 144. Bristol-Myers Squibb Immuno-oncology Diagnosis Product
Table 145. Bristol-Myers Squibb Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 146. Bristol-Myers Squibb Recent Development
Table 147. Cancer Genetics Company Detail
Table 148. Cancer Genetics Business Overview
Table 149. Cancer Genetics Immuno-oncology Diagnosis Product
Table 150. Cancer Genetics Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 151. Cancer Genetics Recent Development
Table 152. Caris Molecular Diagnostics Company Detail
Table 153. Caris Molecular Diagnostics Business Overview
Table 154. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product
Table 155. Caris Molecular Diagnostics Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 156. Caris Molecular Diagnostics Recent Development
Table 157. CellMax Life Company Detail
Table 158. CellMax Life Business Overview
Table 159. CellMax Life Immuno-oncology Diagnosis Product
Table 160. CellMax Life Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 161. CellMax Life Recent Development
Table 162. Charles River Laboratories Company Detail
Table 163. Charles River Laboratories Business Overview
Table 164. Charles River Laboratories Immuno-oncology Diagnosis Product
Table 165. Charles River Laboratories Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 166. Charles River Laboratories Recent Development
Table 167. Chronix Biomedical Company Detail
Table 168. Chronix Biomedical Business Overview
Table 169. Chronix Biomedical Immuno-oncology Diagnosis Product
Table 170. Chronix Biomedical Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 171. Chronix Biomedical Recent Development
Table 172. Circulogene Company Detail
Table 173. Circulogene Business Overview
Table 174. Circulogene Immuno-oncology Diagnosis Product
Table 175. Circulogene Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 176. Circulogene Recent Development
Table 177. Clearbridge BioMedics Company Detail
Table 178. Clearbridge BioMedics Business Overview
Table 179. Clearbridge BioMedics Immuno-oncology Diagnosis Product
Table 180. Clearbridge BioMedics Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 181. Clearbridge BioMedics Recent Development
Table 182. Clinical Genomics Company Detail
Table 183. Clinical Genomics Business Overview
Table 184. Clinical Genomics Immuno-oncology Diagnosis Product
Table 185. Clinical Genomics Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 186. Clinical Genomics Recent Development
Table 187. Pfizer Company Detail
Table 188. Pfizer Business Overview
Table 189. Pfizer Immuno-oncology Diagnosis Product
Table 190. Pfizer Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 191. Pfizer Recent Development
Table 192. Promega Company Detail
Table 193. Promega Business Overview
Table 194. Promega Immuno-oncology Diagnosis Product
Table 195. Promega Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 196. Promega Recent Development
Table 197. Protagen Diagnostics Company Detail
Table 198. Protagen Diagnostics Business Overview
Table 199. Protagen Diagnostics Immuno-oncology Diagnosis Product
Table 200. Protagen Diagnostics Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 201. Protagen Diagnostics Recent Development
Table 202. Qiagen Company Detail
Table 203. Qiagen Business Overview
Table 204. Qiagen Immuno-oncology Diagnosis Product
Table 205. Qiagen Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 206. Qiagen Recent Development
Table 207. Quanterix Company Detail
Table 208. Quanterix Business Overview
Table 209. Quanterix Immuno-oncology Diagnosis Product
Table 210. Quanterix Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 211. Quanterix Recent Development
Table 212. Rarecells SAS Company Detail
Table 213. Rarecells SAS Business Overview
Table 214. Rarecells SAS Immuno-oncology Diagnosis Product
Table 215. Rarecells SAS Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 216. Rarecells SAS Recent Development
Table 217. Roche Diagnostics Company Detail
Table 218. Roche Diagnostics Business Overview
Table 219. Roche Diagnostics Immuno-oncology Diagnosis Product
Table 220. Roche Diagnostics Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 221. Roche Diagnostics Recent Development
Table 222. Siemens Company Detail
Table 223. Siemens Business Overview
Table 224. Siemens Immuno-oncology Diagnosis Product
Table 225. Siemens Revenue in Immuno-oncology Diagnosis Business (2019-2024) & (US$ Million)
Table 226. Siemens Recent Development
Table 227. Research Programs/Design for This Report
Table 228. Key Data Information from Secondary Sources
Table 229. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-oncology Diagnosis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Immuno-oncology Diagnosis Market Share by Type: 2023 VS 2030
Figure 3. PCR Features
Figure 4. NGS Features
Figure 5. Immunoassay Features
Figure 6. Global Immuno-oncology Diagnosis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Immuno-oncology Diagnosis Market Share by Application: 2023 VS 2030
Figure 8. Research Case Studies
Figure 9. Diagnostics Case Studies
Figure 10. Immuno-oncology Diagnosis Report Years Considered
Figure 11. Global Immuno-oncology Diagnosis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Immuno-oncology Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Immuno-oncology Diagnosis Market Share by Region: 2023 VS 2030
Figure 14. Global Immuno-oncology Diagnosis Market Share by Players in 2023
Figure 15. Global Top Immuno-oncology Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Diagnosis as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Immuno-oncology Diagnosis Revenue in 2023
Figure 17. North America Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Immuno-oncology Diagnosis Market Share by Country (2019-2030)
Figure 19. United States Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Immuno-oncology Diagnosis Market Share by Country (2019-2030)
Figure 23. Germany Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Immuno-oncology Diagnosis Market Share by Region (2019-2030)
Figure 31. China Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Immuno-oncology Diagnosis Market Share by Country (2019-2030)
Figure 39. Mexico Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Immuno-oncology Diagnosis Market Share by Country (2019-2030)
Figure 43. Turkey Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Immuno-oncology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. 10x Genomics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 46. Abbott Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 47. Abcam Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 48. Adaptive Biotechnologies Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 49. Aethlon Medical Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 50. Agena Bioscience Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 51. Angle plc Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 52. Apocell Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 53. ARUP Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 54. Beckman Coulter Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 55. Becton Dickinson Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 56. Bioarray Genetics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 57. BioCartis Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 58. Biocept Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 59. Biodesix Inc Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 60. BioFluidica Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 61. BioGenex 40 bioMérieux Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 62. Bio-Rad Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 63. Bio-Techne Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 65. Cancer Genetics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 66. Caris Molecular Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 67. CellMax Life Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 68. Charles River Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 69. Chronix Biomedical Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 70. Circulogene Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 71. Clearbridge BioMedics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 72. Clinical Genomics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 73. Pfizer Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 74. Promega Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 75. Protagen Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 76. Qiagen Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 77. Quanterix Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 78. Rarecells SAS Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 79. Roche Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 80. Siemens Revenue Growth Rate in Immuno-oncology Diagnosis Business (2019-2024)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed